Cells expressing the RING finger Z protein are resistant to arenavirus infection

J Virol. 2004 Mar;78(6):2979-83. doi: 10.1128/jvi.78.6.2979-2983.2004.

Abstract

Arenaviruses include Lassa fever virus (LFV) and the South American hemorrhagic fever viruses. These viruses cause severe human disease, and they pose a threat as agents of bioterrorism. Arenaviruses are enveloped viruses with a bisegmented negative-strand RNA genome whose proteomic capability is limited to four polypeptides: nucleoprotein (NP); surface glycoprotein (GP), which is proteolytically processed into GP1 and GP2; polymerase (L); and a small (11-kDa) RING finger protein (Z). Our investigators have previously shown that Z has a strong inhibitory activity on RNA synthesis mediated by the polymerase of the prototypic arenavirus, lymphocytic choriomeningitis virus (LCMV). In this report we show that cells transduced with a replication-deficient recombinant adenovirus expressing Z (rAd-Z) are resistant to LCMV and LFV infection. Virus cell entry mediated by LCMV or LFV GP was not affected in rAd-Z-transduced cells, but both virus transcription and replication were strongly and specifically inhibited, which resulted in a dramatic reduction in production of infectious virus. These findings open new avenues for developing antiviral strategies to combat the highly pathogenic human arenaviruses, including LFV.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Arenaviridae Infections / virology
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Carrier Proteins / pharmacology*
  • Chlorocebus aethiops
  • Fatty Acid-Binding Proteins
  • Humans
  • Lassa virus / drug effects
  • Lassa virus / metabolism
  • Lassa virus / pathogenicity*
  • Lymphocytic choriomeningitis virus / drug effects
  • Lymphocytic choriomeningitis virus / metabolism
  • Lymphocytic choriomeningitis virus / pathogenicity*
  • Transcription, Genetic / drug effects
  • Transduction, Genetic
  • Vero Cells
  • Virus Replication / drug effects

Substances

  • Carrier Proteins
  • Fatty Acid-Binding Proteins